ACB
Aurora Cannabis Inc
NASDAQ · Pharmaceuticals
$3.48
+0.17 (+5.14%)
Open$3.43
Previous Close$3.31
Day High$3.49
Day Low$3.38
52W High$22.86
52W Low$9.68
Volume—
Avg Volume222.3K
Market Cap256.30M
P/E Ratio20.85
EPS$0.87
SectorPharmaceuticals
Analyst Ratings
Buy
9 analysts
Price Target
+481.0% upside
Current
$3.48
$3.48
Target
$20.22
$20.22
$15.45
$20.22 avg
$24.58
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 69.57M | 70.84M | 65.30M |
| Net Income | 9.88M | 13.06M | 12.20M |
| Profit Margin | 14.2% | 18.4% | 18.7% |
| EBITDA | 20.53M | 20.07M | 20.48M |
| Free Cash Flow | 10.78M | 11.95M | 8.74M |
| Rev Growth | +1.6% | +2.1% | +23.7% |
| Debt/Equity | 0.14 | 0.16 | 0.16 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |